Literature DB >> 10794929

Application of Carbopol to controlled release preparations I. Carbopol as a novel coating material.

M Muramatsu1, K Kanada, A Nishida, K Ouchi, N Saito, M Yoshida, A Shimoaka, T Ozeki, H Yuasa, Y Kanaya.   

Abstract

We investigated the application of Carbopol(R) (CP) as a novel coating material prepared with various grades of CP having different degrees of cross-linking and molecular weights. Viscosity and spray mist size of CP aqueous solutions at various concentrations of CP were measured. Core tablets containing theophylline (TP), as a model drug, were coated with CP at various coating ratios. The TP release profile from the CP-coated tablets was studied by the JP13 paddle method. CP tablets were prepared by compressing CP powder, and the swelling behavior of the CP tablets in JP 1st fluid, purified water, and JP 2nd fluid was observed. The spray mist size of all CP aqueous solutions was small at a concentration of 1% and below, and drastically increased over a concentration of 1%. This result suggests that the appropriate concentration of the CP solution for coating is 1% or below. Sustained release of TP from the CP-coated tablets at a coating ratio of only 3% was observed in the JP 1st fluid and purified water, although fast release was observed in the JP 2nd fluid. The fast release in the latter fluid may be due to the fact that CP is an acid material. These results suggest that it is feasible to control the drug release by use of an extremely small amount of CP coating and that CP is useful as a novel coating material.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10794929     DOI: 10.1016/s0378-5173(00)00374-4

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Study on of bioadhesive property of carbomer 934 by a gamma camera in vivo.

Authors:  Jie Fu; Xun Sun; Zhi-Rong Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Microencapsulation Approach for Orally Extended Delivery of Glipizide: In vitro and in vivo Evaluation.

Authors:  A Abdelbary; N A El-Gendy; A Hosny
Journal:  Indian J Pharm Sci       Date:  2012-07       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.